216 filings
Page 5 of 11
UPLOAD
cswm1jx16q3tfx4
29 Sep 20
Letter from SEC
12:00am
8-K
193g1u
13 Aug 20
Novocure Announces Expansion of its Executive Leadership Team
8:45am
8-K
kgzapho79flj rz8
6 Aug 20
Termination of a Material Definitive Agreement
4:09pm
8-K
9rz02
30 Jul 20
Novocure Reports Second Quarter 2020 Financial Results and Provides Company Update
8:11am
8-K
2fm1ua6s735noklqm5
15 Jul 20
Regulation FD Disclosure
10:38am
8-K
567jom40t2ddq9awp
12 Jun 20
Departure of Directors or Certain Officers
4:10pm
8-K
xwlz59
13 May 20
China NMPA Approves OptuneĀ® for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
10:19am
8-K
amycxiiq3q3rro7rr
30 Apr 20
Novocure Reports First Quarter 2020 Financial Results and Provides Company Update
6:13am
DEFA14A
wc8tt0da 43rj59
27 Apr 20
Additional proxy soliciting materials
4:45pm
8-K
5tdmu55fi zzfsd4
24 Apr 20
Departure of Directors or Certain Officers
5:19pm
8-K
0netpbgb5lev
6 Mar 20
Departure of Directors or Certain Officers
4:19pm
S-8
cbp an6q9ofer19jgv4
3 Mar 20
Registration of securities for employees
4:05pm
8-K
47pni9aw6goz mgq1
27 Feb 20
Novocure Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Company Update
6:07am
8-K
hp359kfus9t0hg
13 Jan 20
Novocure Announces Fourth Quarter and Full Year 2019 Preliminary Net Revenues and Provides Company Update
7:25am